|
Louis M. Weiner, M.D. is Chairman, Department of Medical Oncology and the G. Morris Dorrance, Jr. Professor of Medical Science at Fox Chase Cancer Center. Dr. Weiner’s research centers on the use of antibody-based molecules to target tumors, with an emphasis on understanding the principles of tumor targeting and the use of antibodies to initiate host immune-mediated tumor lysis. He has been at the forefront of efforts to develop antibody-based therapies of human cancer. Dr. Weiner has been a pioneer in the use of antibody engineering to improve selective tumor targeting and to manipulate antibody-directed immune effector functions. Dr. Weiner received his MD from Mount Sinai School of Medicine in 1977 and his BA with Honors in Biology from the University of Pennsylvania in 1973. | 